Get the Stockscreener App
1.25
2.34%
-0.03
After Hours:
1.25
Promis Neurosciences Inc stock is traded at $1.25, with a volume of 37,770.
It is down -2.34% in the last 24 hours and down -8.51% over the past month.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
See More
Previous Close:
$1.28
Open:
$1.36
24h Volume:
37,770
Relative Volume:
0.25
Market Cap:
$38.25M
Revenue:
-
Net Income/Loss:
$-16.90M
P/E Ratio:
-0.4808
EPS:
-2.6
Net Cash Flow:
$-11.64M
1W Performance:
+1.63%
1M Performance:
-8.51%
6M Performance:
-34.55%
1Y Performance:
-36.88%
1-Day Range:
$1.225
$1.36
1-Week Range:
$1.2201
$1.45
52-Week Range:
$0.95
$3.10
Promis Neurosciences Inc Stock (PMN) Company Profile
Name
Promis Neurosciences Inc
Sector
Industry
Phone
416-847-6898
Address
SUITE 200, 1920 YONGE STREET, TORONTO
Promis Neurosciences Inc Stock (PMN) Latest News
ProMIS Neurosciences (NASDAQ:PMN) versus Rigel Pharmaceuticals (NASDAQ:RIGL) Head-To-Head Analysis - Defense World
ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying - MSN
ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Madge K. Shafmaster Acquires 60,000 Shares - Defense World
Director Madge Shafmaster Acquires 200,000 Shares of ProMIS Neur - GuruFocus.com
ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Buys $89,600.00 in Stock - Defense World
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock By Investing.com - Investing.com South Africa
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock By Investing.com - Investing.com Australia
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock - Investing.com
ProMIS Neurosciences director Shafmaster purchases $255,750 in stock By Investing.com - Investing.com Canada
ProMIS Neurosciences (NASDAQ:PMN) versus Regulus Therapeutics (NASDAQ:RGLS) Critical Contrast - Defense World
BSE SME Popular Foundation slips on debut - Business Standard
Popular Foundations shares list at IPO price on BSE SME platform - The Economic Times
Popular Foundations makes tepid debut, shares list flat at ₹37 apiece on BSE SME platform - Upstox
How To Check Popular Foundations IPO Allotment Status - NDTV Profit
Taking a look at what insiders are doing to gauge the PureCycle Technologies Inc (PCT)’s direction - Knox Daily
ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
Popular Foundations IPO allotment to be finalized today - IPO Watch
Prosperity Bancshares, Inc. (NYSE:PB) Shares Bought by Federated Hermes Inc. - Defense World
The Psychology of PureCycle Technologies Inc Inc. (PCT) Price Performance: Understanding Market Sentiment - The InvestChronicle
ProMIS Neurosciences to Showcase PMN310’s Ability to Target - GlobeNewswire
ProMIS unveils promising Alzheimer's antibody data at ICBN By Investing.com - Investing.com Australia
ProMIS unveils promising Alzheimer's antibody data at ICBN - Investing.com India
Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews
ProMIS unveils promising Alzheimer's antibody data at ICBN By Investing.com - Investing.com Canada
ProMIS unveils promising Alzheimer's antibody data at ICBN - Investing.com
ProMIS Neurosciences (NASDAQ:PMN) Trading Down 5% - Defense World
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Around $2M Bet On This Health Care Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying - Benzinga
Patrick D. Kirwin Buys 10,000 Shares of ProMIS Neurosciences, Inc. (NASDAQ:PMN) Stock - Defense World
Origin Energy Limited (OGFGY) to Issue Dividend of $0.15 on October 11th - Defense World
Dominion Lending Centres Inc. (DLC) To Go Ex-Dividend on August 30th - Defense World
Promis Neurosciences director buys $12,492 in company stock By Investing.com - Investing.com Canada
Promis Neurosciences director buys $12,492 in company stock - Investing.com India
Promis Neurosciences director buys $12,492 in company stock By Investing.com - Investing.com Australia
Promis Neurosciences director buys $12,492 in company stock - Investing.com
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket - Benzinga
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q2 2024 - MSN
ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights - GlobeNewswire
ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights - StockTitan
PMNProMIS Neurosciences, Inc. Latest Stock News & Market Updates - StockTitan
ProMIS Neurosciences Announces Data on the Pathogenic Role - GlobeNewswire
ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology - StockTitan
ProMIS Neurosciences insider purchases shares worth over $1 million - Investing.com
ProMIS Neurosciences insider purchases shares worth over $1 million - Investing.com India
ProMIS Neurosciences insider purchases shares worth over $1 million By Investing.com - Investing.com Canada
Promis Neurosciences insider acquires over $1 million in shares - Investing.com
Promis Neurosciences insider acquires shares worth $1.5m By Investing.com - Investing.com Canada
Promis Neurosciences insider acquires shares worth $1.5m - Investing.com
Promis Neurosciences insider acquires shares worth $1.5m By Investing.com - Investing.com UK
Promis Neurosciences Inc Stock (PMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):